吸入性抗喘疗法和儿童和青少年的牙磨损:一个病例控制研究
Magdalena Świątkowska-Bury1, Anna Zawadzka-Krajewska2, Marek Kulus2
1Department of Pediatric Dentistry, Medical University of Warsaw, 6 Binieckiego Street, 02-097 , Warsaw, Poland.
Scientific reports
|November 18, 2025
概括
吸入性喘药物,特别是组合疗法和干粉吸入器,与儿童和青少年的牙磨损增加有关. 使用后冲洗口腔可能有助于减少这种牙风险.
科学领域:
- 儿科牙科 儿科牙科
- 呼吸系统医学 呼吸系统医学
- 临床药理学 临床药理学
背景情况:
- 喘管理经常涉及吸入药物.
- 吸入疗法对口腔健康的潜在副作用需要调查.
- 牙磨损是一种影响儿童和青少年的多因素状况.
研究的目的:
- 调查吸入性抗喘疗法与儿科患者牙磨损之间的关联.
- 分析药物类型,持续时间和输送方法对牙磨损的影响.
- 为了探索像GERD和饮食习惯这样的共同存在的因素.
主要方法:
- 一项涉及129名儿童和青少年的病例控制研究 (70名喘患者,59名对照).
- 使用史密斯和骑士牙磨损指数 (TWI) 评估牙磨损.
- 通过临床采访和医疗记录收集关于药物,饮食,卫生和GERD的数据.
主要成果:
- 喘患者的牙磨损明显高于对照组 (p=0.0025).
- 牙磨损与ICS/LABA联合治疗,高剂量的ICS,更长时间的治疗和干粉吸入器 (DPI) 使用相关.
- 胃食道逆流性疾病 (GERD) 在喘患者中更为普遍,并且与口腔磨损有关.
结论:
- 吸入性喘疗法,特别是组合疗法和DPI,增加了儿科患者牙磨损的风险.
- 建议包括吸入器后的口腔冲洗和定期的牙科检查.
- 跨学科的合作对于减轻喘儿童口腔健康风险至关重要.
相关概念视频
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Antiasthma Drugs: Methylxanthines
1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K


